Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

McSweeney KR, Gadanec LK, Qaradakhi T, Ali BA, Zulli A, Apostolopoulos V. · 2021

Read Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. by McSweeney KR, Gadanec LK, Qaradakhi T, Ali BA, Zulli A, Apostolopoulos V. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8036620.txt.

Description

McSweeney and co-authors consolidate what is known about cisplatin-induced acute kidney injury. Cisplatin is a potent chemotherapy, approved in 1978 and used against many cancers. Kidney damage is its dose-limiting harm. The injury can ease, yet signs linger years after treatment ends. No drug reliably prevents it. The authors blame the tangled map of causes.

The review walks through each mechanism in turn. Cellular uptake and efflux, apoptosis, and vascular injury all play roles. Oxidative stress, endoplasmic reticulum stress, and inflammation join them. For every mechanism, the authors list the drugs tested against it. They report what each trial or study found. Genetic modification studies close the survey. Some gene changes blunted the disease in models, hinting at future shields.

Catalog record

CREATORMcSweeney KR, Gadanec LK, Qaradakhi T, Ali BA, Zulli A, Apostolopoulos V.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE171 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8036620

Browse the full library · About the Tower of Babel